Biologic drugs are a big deal for the pharmaceutical industry right now. Blockbuster chemicals for common conditions like diabetes and hypertension are largely things of the past. We’re getting pretty good at controlling those conditions, and few people expect a slew of major scientific breakthroughs that will lead to many more multibillion dollar treatments for…
Euphemistically referred to as Consumer-Directed Health Plans, high out-of-pocket insurance is in theory supposed to incentivize people to scrutinize the cost and quality of their medical care, thus bringing pressure on providers to lower the price and/or raise the quality of their services. This theory isn’t borne out in practice. As a matter of practice…
One of the greatest joys of practicing medicine is for me to understand where my patients are coming from, so I can best help them through their medical journey. I was reminded of this fact recently, when talking with a patient who had just come back to my primary care clinic after visiting the liver…
I spoke the other day to Melissa Dahl, a writer for New York Magazine. She wrote a really nice piece on what medical professionals call “contralateral prophylactic mastectomy” – when a woman with breast cancer chooses not only to remove the affected breast, but also the unaffected breast in order to reduce the chance of…
I expect most of us agree that an incarcerated felon experiencing a heart attack should receive medical treatment, even if that treatment comes at taxpayers’ expense. The same probably goes for more preventive measures—blood pressure pills, cancer screening tests and the like. While serving out the sentence for their crimes, prisoners should not be forced…
For decades now, policymakers have been trying to slow down the growth of healthcare costs. For much of this time, a large part of that effort was directed at hospital spending. American hospitals are extremely expensive, and take care of patients with the most severe illnesses. So if we’re going to control costs, it seems…